Editas Medicine Inc
EDIT
NASDAQ
Biotechnology
$2.82
USD
+0.01 (+0.36%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $441.54M
Volume 1.5M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SCTX | Scribe Therapeutics Inc | - | - | - | - | |
QTTB | Q32 Bio Inc | $468.57M | 15.71 | - | - | |
OCGN | Ocugen Inc | $457.80M | - | +0.4% | - | |
PBYI | Puma Biotechnology Inc | $454.88M | 18.65 | -2.4% | - | |
CABA | Cabaletta Bio Inc | $451.25M | - | - | - | |
RZLT | Rezolute Inc | $450.65M | - | - | - | |
EDIT | Editas Medicine Inc | $441.54M | - | +20.8% | - | |
LRMR | Larimar Therapeutics Inc | $416.57M | - | - | - | |
ABEO | Abeona Therapeutics Inc | $363.91M | 5.50 | - | - | |
STRO | Sutro Biopharma Inc | $360.08M | - | +49.9% | - |
Top Peer by Growth
Prokidney Corp
+190.5% YoY Revenue
Best 1-Year Return
Prelude Therapeutics Inc
+583.8% Return